Owens & Minor, Inc. (NYSE:OMI – Free Report) – Analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Owens & Minor in a report issued on Monday, August 11th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $0.24 per share for the quarter, down from their previous estimate of $0.44. The consensus estimate for Owens & Minor’s current full-year earnings is $1.51 per share. Leerink Partnrs also issued estimates for Owens & Minor’s Q4 2025 earnings at $0.23 EPS, FY2026 earnings at $0.97 EPS, FY2027 earnings at $1.18 EPS and FY2028 earnings at $1.36 EPS.
Owens & Minor (NYSE:OMI – Get Free Report) last announced its quarterly earnings data on Monday, August 11th. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.27 by ($0.01). The company had revenue of $681.90 million during the quarter, compared to the consensus estimate of $2.73 billion. Owens & Minor had a negative net margin of 13.78% and a positive return on equity of 26.59%. Owens & Minor’s revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.36 EPS.
Read Our Latest Report on Owens & Minor
Owens & Minor Stock Performance
Shares of NYSE OMI opened at $5.41 on Thursday. The stock has a 50 day moving average price of $7.67 and a 200 day moving average price of $7.96. Owens & Minor has a 52 week low of $4.56 and a 52 week high of $16.63. The company has a debt-to-equity ratio of 3.32, a quick ratio of 0.41 and a current ratio of 0.86. The stock has a market capitalization of $417.48 million, a PE ratio of -0.35, a price-to-earnings-growth ratio of 0.38 and a beta of 1.04.
Institutional Trading of Owens & Minor
Several institutional investors and hedge funds have recently bought and sold shares of OMI. LPL Financial LLC bought a new stake in Owens & Minor in the fourth quarter valued at approximately $617,000. JPMorgan Chase & Co. increased its stake in shares of Owens & Minor by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 488,497 shares of the company’s stock worth $6,385,000 after purchasing an additional 111,667 shares during the period. Wells Fargo & Company MN increased its stake in shares of Owens & Minor by 24.6% during the fourth quarter. Wells Fargo & Company MN now owns 48,039 shares of the company’s stock worth $628,000 after purchasing an additional 9,484 shares during the period. Russell Investments Group Ltd. increased its stake in shares of Owens & Minor by 31.0% during the fourth quarter. Russell Investments Group Ltd. now owns 192,492 shares of the company’s stock worth $2,515,000 after purchasing an additional 45,576 shares during the period. Finally, Legal & General Group Plc increased its stake in shares of Owens & Minor by 0.9% during the fourth quarter. Legal & General Group Plc now owns 212,061 shares of the company’s stock worth $2,772,000 after purchasing an additional 1,991 shares during the period. Institutional investors own 98.04% of the company’s stock.
Insider Transactions at Owens & Minor
In other Owens & Minor news, major shareholder Coliseum Capital Management, L acquired 492,852 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were purchased at an average price of $5.31 per share, for a total transaction of $2,617,044.12. Following the completion of the purchase, the insider directly owned 13,100,807 shares of the company’s stock, valued at approximately $69,565,285.17. This represents a 3.91% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders purchased a total of 1,537,852 shares of company stock valued at $8,099,544 in the last 90 days. 3.69% of the stock is owned by corporate insiders.
About Owens & Minor
Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.
See Also
- Five stocks we like better than Owens & Minor
- How to Short Nasdaq: An Easy-to-Follow Guide
- How Did Peter Thiel-Backed Crypto Exchange Bullish’s IPO Go?
- Industrial Products Stocks Investing
- Mercury Systems Up 27%: Financials Send Investors a Clear Signal
- Investing in Commodities: What Are They? How to Invest in Them
- Deereās Sell-Off Could Be a Long-Term Buying Chance
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.